Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fludrocortisone Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 25,078Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus gains FDA approval for Fludrocortisone Acetate Tablets
    Zydus gains FDA approval for Fludrocortisone Acetate Tablets

    18 Oct 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/zydus-gains-final-usfda-approval-for-fludrocortisone-acetate-tablets-usp-0-1-mg/

    EXPRESSPHARMA
    18 Oct 2024
    Share Share
    Enforcement Report - Week of July 24, 2024
    Enforcement Report - Week of July 24, 2024

    24 Jul 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-24-2024-12306.pdf

    FDA
    24 Jul 2024
    Share Share
    Hikma's Generic Fludrocortisone Acetate Receives Approval in the U.S.
    Hikma's Generic Fludrocortisone Acetate Receives Approval in the U.S.

    27 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216013

    FDA
    27 Oct 2022
    Share Share
    ANI Pharma Announces FDA Approval and Launch of Fludrocortisone Acetate Tablets
    ANI Pharma Announces FDA Approval and Launch of Fludrocortisone Acetate Tablets

    01 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220601006212/en

    BUSINESSWIRE
    01 Jun 2022
    Share Share
    CMA pins down Tiofarma for illegal market sharing
    CMA pins down Tiofarma for illegal market sharing

    25 Jan 2020

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/cma_pins_down_tiofarma_for_illegal_market_sharing_1323304

    Anna Smith PHARMA TIMES
    25 Jan 2020
    Share Share
    Tiofarma admits role in illegal agreement causing fludrocortisone price hikes
    Tiofarma admits role in illegal agreement causing fludrocortisone price hikes

    24 Jan 2020

    // EUROPEANPHARMACEUTICALS

    https://www.europeanpharmaceuticalreview.com/news/111429/tiofarma-admits-role-in-illegal-agreement-causing-fludrocortisone-price-hikes/

    EUROPEANPHARMACEUTICALS
    24 Jan 2020
    Share Share